Martin Smoragiewicz

Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer

Vinod P. Balachandran, Marta Łuksza, Julia N. Zhao et al. · Nature · 2017 · 1.2K citations · Full text

Medicine, Cancer Biology, Oncology +11

The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study

Jenny J. Ko, Wanling Xie, Nils Kroeger et al. · The Lancet Oncology · 2015 · 375 citations · Full text

Medicine, Nephrology, Oncology +14

CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response

Daniele Biasci, Martin Smoragiewicz, Claire M. Connell et al. · Proceedings of the National Academy of Sciences · 2020 · 258 citations · Full text

Life Sciences, Immunology, Oncology +17

Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy

Arnoud J. Templeton, Jennifer J. Knox, Xun Lin et al. · European Urology · 2016 · 151 citations · Full text

Medicine, Immunology, Oncology +14

Characterizing the Impact of Lymph Node Metastases on the Survival Outcome for Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapies

Nils Kroeger, Allan J. Pantuck, J. Connor Wells et al. · European Urology · 2014 · 43 citations

Medicine, Cancer Biology, Oncology +16